Share This

普利制藥年報「難產」背後:前兩年應收款、預付款激增,四年前成立的孫公司成母公司最大應收款單位

2024-05-08T10:02
Related Stocks:  <600837.SS> -  

... 普利制藥(300630.SZ,股價12.35元,市值55.79億元)原定於4月30日披露2023年年報,最終卻向投資者交出一份爽約公告。 大半個月前,海南證監局向普利制藥(300630)發出行政監管措施決定書,經現場檢查發現該企業2021年、2022年年度報告中的營業收入、利潤等財務信息披露不准確,海南證監局要求普利制藥對相關年度營業收入、利潤等財務信息的真實性、准確性進行自查

...
 recommend this page to friend   Details 
Name Updated Value Change Change %
- 05-13 15:00 12.71  0.03  0.24%
 
 
 Related news
  Search   More 
 Latest News
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.